Patents by Inventor Christine Joseph

Christine Joseph has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HOMOLOGOUS ADENOVIRAL VACCINATION
    Publication number: 20240093235
    Abstract: Disclosed are nucleotides, cells, and methods associated with the compositions including their use as vaccines, including vectors and methods for a homologous prime/boost vaccination strategy, such as adenoviral vectors for use in a homologous prime/boost vaccination strategy.
    Type: Application
    Filed: December 3, 2021
    Publication date: March 21, 2024
    Inventors: Karin Jooss, Ciaran Daniel Scallan, Leonid Gitlin, Andrew Ferguson, Raphael Rousseau, Roman Yelensky, James Xin Sun, Matthew Joseph Davis, Amy Rachel Rappaport, Christine Denise Palmer
  • AUTOIMMUNE ANTIGENS AND CANCER
    Publication number: 20210100882
    Abstract: Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Analyses of peripheral blood lymphocytes and serum suggested that mutations in autoimmune antigen targets sparked cellular immunity and cross-reactive humoral immune responses. Acquired immunity to autoimmune antigens can help control naturally occurring cancers.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 8, 2021
    Inventors: Erika Darrah, Ami A. Shah, Livia A. Casciola-Rosen, Antony Rosen, Christine Joseph, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos
  • Autoimmune antigens and cancer
    Patent number: 10874726
    Abstract: Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Analyses of peripheral blood lymphocytes and serum suggested that mutations in autoimmune antigen targets sparked cellular immunity and cross-reactive humoral immune responses. Acquired immunity to autoimmune antigens can help control naturally occurring cancers.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: December 29, 2020
    Assignee: The Johns Hopkins University
    Inventors: Erika Darrah, Ami A. Shah, Livia A. Casciola-Rosen, Antony Rosen, Christine Joseph, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos
  • Autoimmune Antigens and Cancer
    Publication number: 20160303209
    Abstract: Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Analyses of peripheral blood lymphocytes and serum suggested that mutations in autoimmune antigen targets sparked cellular immunity and cross-reactive humoral immune responses. Acquired immunity to autoimmune antigens can help control naturally occurring cancers.
    Type: Application
    Filed: December 4, 2014
    Publication date: October 20, 2016
    Applicant: The Johns Hopkins University
    Inventors: Erika Darrah, Ami A. Shah, Livia A. Casciola-Rosen, Anthony Rosen, Christine Joseph, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos